• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌:泰国诗里拉吉医院的五年生存率

Breast cancer: five-year survival in Srinagarind Hospital, Thailand.

作者信息

Aphinives Potchavit, Punchai Suriya, Vajirodom Damnern, Bhudhisawasdi Vajarabhongsa

机构信息

Department of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

出版信息

J Med Assoc Thai. 2010 Mar;93 Suppl 3:S25-9.

PMID:21299088
Abstract

BACKGROUND

Breast cancer is the second most common cancer among Thai women after cancer of the cervix.

OBJECTIVE

To investigate the overall five-year survival of breast cancer patients treated at Srinagarind hospital.

MATERIAL AND METHOD

Between January 1998 and December 2002, 382 patients with breast cancer who got definite treatment at Srinagarind hospital were included in the present study. Their medical records were reviewed including sex, age, stage at diagnosis, histological types, histological grades, treatment modality and survival.

RESULTS

There were 380 female patients (99.5%) and 2 male patients (0.5%). The peak age group was 41-50 years (38.5%), mean age was 48.3 years old. The most common histological type was invasive ductal carcinoma (95.3%). Most patients received surgical treatment (91.9%) and chemotherapy (94.2%). The overall five-year survival rate was 63%. The overall five-year survival rate in stage I, II, III and IV were 100%, 85%, 39% and 9% respectively.

CONCLUSION

The peak age of breast cancer was 41-50 years old. The overall five-year survival rate was 63%.

摘要

背景

乳腺癌是泰国女性中仅次于宫颈癌的第二大常见癌症。

目的

调查在诗里拉吉医院接受治疗的乳腺癌患者的总体五年生存率。

材料与方法

1998年1月至2002年12月期间,纳入了382例在诗里拉吉医院接受明确治疗的乳腺癌患者。回顾了他们的病历,包括性别、年龄、诊断时的分期、组织学类型、组织学分级、治疗方式和生存情况。

结果

有380例女性患者(99.5%)和2例男性患者(0.5%)。年龄峰值组为41 - 50岁(38.5%),平均年龄为48.3岁。最常见的组织学类型是浸润性导管癌(95.3%)。大多数患者接受了手术治疗(91.9%)和化疗(94.2%)。总体五年生存率为63%。I期、II期、III期和IV期的总体五年生存率分别为100%、85%、39%和9%。

结论

乳腺癌的年龄峰值为41 - 50岁。总体五年生存率为63%。

相似文献

1
Breast cancer: five-year survival in Srinagarind Hospital, Thailand.乳腺癌:泰国诗里拉吉医院的五年生存率
J Med Assoc Thai. 2010 Mar;93 Suppl 3:S25-9.
2
[Clinical analysis of resectable breast cancer: a report of 6 263 cases].可切除乳腺癌的临床分析:6263例报告
Ai Zheng. 2005 Mar;24(3):327-31.
3
[Multi-modal treatment in breast cancer. The prognostic role and correlation between relapse and metastasis].[乳腺癌的多模态治疗。复发与转移之间的预后作用及相关性]
Rev Med Chir Soc Med Nat Iasi. 2009 Jul-Sep;113(3):941-6.
4
Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer.研究初次治疗医院与乳腺癌女性患者生存率之间的相关性。
Cancer. 2005 Oct 1;104(7):1343-8. doi: 10.1002/cncr.21336.
5
Similarities and differences in the characteristics and primary treatment of breast cancer in men and women - a population based study (Sweden).男性和女性乳腺癌特征和主要治疗的异同——基于人群的研究(瑞典)。
Acta Oncol. 2011 Oct;50(7):1083-8. doi: 10.3109/0284186X.2011.602114. Epub 2011 Aug 11.
6
Male breast cancer: a survey at the Helsinki University Central Hospital during 1981-2006.男性乳腺癌:1981 年至 2006 年赫尔辛基大学中心医院的调查。
Acta Oncol. 2010 Apr;49(3):322-7. doi: 10.3109/02841861003591723.
7
A single-center experience with inflammatory breast cancer, 1985-2003.1985年至2003年炎性乳腺癌的单中心经验
Arch Surg. 2006 Jun;141(6):567-72; discussion 572-3. doi: 10.1001/archsurg.141.6.567.
8
[Breast cancer in the man: a report of 30 patients].男性乳腺癌:30例患者的报告
Wien Klin Wochenschr. 1994;106(18):575-80.
9
Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.乳腺癌的局部区域复发:治疗方法的回顾性比较
Neoplasma. 2002;49(6):426-31.
10
Therapy and survival in male breast carcinoma: A retrospective analysis of 50 cases.男性乳腺癌的治疗与生存情况:50例病例的回顾性分析
Oncol Rep. 2000 Sep-Oct;7(5):1035-9.

引用本文的文献

1
Breast Cancer Survival and Incidence: 10 Years Cancer Registry Data in the Northwest, Iran.乳腺癌生存率与发病率:伊朗西北部癌症登记处10年数据
Int J Breast Cancer. 2020 May 1;2020:1963814. doi: 10.1155/2020/1963814. eCollection 2020.
2
Current Status and Future Projections of Breast Cancer in Asia.亚洲乳腺癌的现状与未来预测
Breast Care (Basel). 2015 Dec;10(6):372-8. doi: 10.1159/000441818. Epub 2015 Dec 15.